FDW
GILD icon

Fourth Dimension Wealth’s Gilead Sciences GILD Stock Holding History

Fourth Dimension Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.2K Sell
643
-5
-0.8% -$659 0.03% 215
2026
Q1 		$90.3K Hold
648
– – 0.03% 182
2025
Q4 		$79.5K Hold
648
– – 0.03% 195
2025
Q3 		$71.9K Buy
648
+68
+12% +$7.73K 0.03% 197
2025
Q2 		$64.3K Hold
580
– – 0.03% 205
2025
Q1 		$65K Hold
580
– – 0.03% 198
2024
Q4 		$53.6K Buy
+580
New +$52.2K 0.03% 215

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fourth Dimension Wealth's GILD Position: Q2 2026 in Review

Fourth Dimension Wealth reduced its Gilead Sciences (GILD) stake by 0.77% in Q2 2026, selling an estimated $659 and leaving 643 shares worth $81.2K. The position accounts for 0.03% of the portfolio, ranked #215.

Fourth Dimension Wealth first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $90.3K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fourth Dimension Wealth held 643 shares of Gilead Sciences worth $81.2K as of Q2 2026.
  • Fourth Dimension Wealth sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.03% of Fourth Dimension Wealth's portfolio in Q2 2026, its #215 holding.
  • Fourth Dimension Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Fourth Dimension Wealth's Gilead Sciences position peaked at $90.3K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.